Thomas, A., Wolf, D. M., Balassanian, R., Chen, Y.-Y., Ye, J., Vohra, P., … Esserman, L. (2024). Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Thomas, Alexandra, Denise M. Wolf, Ronald Balassanian, Yunn-Yi Chen, Julia Ye, Poonam Vohra, Evin H. Gulbahce, et al. “Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Thomas A, Wolf DM, Balassanian R, Chen Y-Y, Ye J, Vohra P, et al. Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Thomas, Alexandra, et al. “Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Thomas A, Wolf DM, Balassanian R, Chen Y-Y, Ye J, Vohra P, Gulbahce EH, Borowsky AD, Swigart LB, Hirst GL, Venters S, Nanda R, Shatsky RA, D’Agostino RJ, Mukhtar RA, Hatcher S, Yau C, DeMichele A, van’t Veer L, Esserman L. Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022. JOURNAL OF CLINICAL ONCOLOGY. 2024.